Takayasu’s arteritis progression on anti-TNF biologics: a case series

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

Filip Baert, Maja Noman, Séverine Vermeire et al. · New England Journal of Medicine · 2003 · 2K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis

Marijn Vis, Willem F. Lems, Alexandre E. Voskuyl et al. · Arthritis & Rheumatism · 2006 · 469 citations

Medicine, Clinical Sciences, Internal Medicine +17

The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: Results from ATTRACT, a multicenter, randomized, double‐blind, placebo‐controlled trial

E. William St. Clair, Carrie Wagner, Adedigbo A. Fasanmade et al. · Arthritis & Rheumatism · 2002 · 423 citations

Medicine, Pharmacology, Pharmacotherapy +13

Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up

Eamonn Molloy, Carol A. Langford, Tiffany Clark et al. · Annals of the Rheumatic Diseases · 2008 · 253 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +11

Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study

G. M. Bartelds, Carla A. Wijbrandts, Michael T. Nurmohamed et al. · Annals of the Rheumatic Diseases · 2009 · 223 citations · Full text

Life Sciences, Immunology, Internal Medicine +16